|
Faculty
Marlene Hauck, DVM, PhD
Associate Professor, Oncology
Doctor
of Veterinary Medicine, Colorado State University
Doctor
of Philosophy, Duke University
Diplomate, American College of Veterinary Internal Medicine
(Oncology)
Phone:
919.513.8274
Fax:
919.513.6336
Email: marlene_hauck@ncsu.edu
Specialty
- Treatment
of solid and hematopoietic tumors
- Clinical
trials of novel therapeutic agents
Professional
Experience & Qualifications
July
2005-present: Associate
Professor of Oncology, North Carolina State University,
College of Veterinary Medicine, Department of
Clinical Sciences, Raleigh, NC
July
2000- July 2005:
Assistant Professor of Oncology, North Carolina
State University, College of Veterinary Medicine,
Department of Clinical Sciences, Raleigh, NC
July
1996- July 2000:
Research Assistant Professor, North Carolina
State University, College of Veterinary
Medicine, Department of Clinical Sciences,
Raleigh, NC
1999-present:
Research Associate, Duke University, Durham,
NC
1990-1992: Resident,
Oncology, North Carolina State University,
College of Veterinary Medicine,
Raleigh, NC
1989-1990:
Intern, Small Animal Medicine and Surgery,
University of Illinois, College
of Veterinary Medicine, Urbana, IL |
Research
Area
- Targeted
therapeutics
- Hyperthermia
Clinical Trials
Selected
Publications
Phillips JC, Stephenson B, Hauck M, Dillberger J. Heritability and segregation analysis of osteosarcoma in the Scottish deerhound. Genomics 2007;90(3):354-63.
Siddiqui F, Li C-Y, LaRue SM, Poulson JM, Avery PR, Pruitt AF, Zhang X, Ullrich RL, Thrall DE, Dewhirst MW, Hauck ML. A phase I trial of hyperthermia-induced interleukin-12 gene-therapy in spontaneously arising feline soft tissue sarcomas. Molecular Cancer Therapeutics 2007;6(1):380-389.
Hauck ML, LaRue SM, Petros WP, Poulson JM, Yu D, Spasojevic I, Pruitt AF, Klein A, Case B, Thrall DE, Needham D, Dewhirst MW. Phase I Trial of Doxorubicin-Containing Low-Temperature Sensitive Liposomes in Spontaneous Canine Tumors. Clinical Cancer Research 2006;12(13):4004-4010.
Kleiter MM, Yu D, Mohammadian LA, Niehaus N, Spasojevic I, Sanders L, Viglianti BL, Pavel S.Yarmolenko PS, Hauck M, Petry NA, Wong TZ, Dewhirst MW, Thrall DE. A Tracer Dose of Technetium-99m Labeled Liposomes Can Estimate the Effect of Hyperthermia on Intratumoral Doxil Extravasation. Clinical Cancer Research 2006;12(22):6800-6807.
Heller DA, Stebbins ME, Reynolds TL, Hauck, ML. A retrospective study of canine soft tissue sarcomas: 87 cases (1991-2001). International Journal of Applied Research in Veterinary Medicine 2005;3(2):81-87.
Hauck ML, Zalutsky MR. Enhanced tumor uptake of radiolableled antibodies by hyperthermia: Part II: effect of heating protocol. International Journal of Hyperthermia 2005;21(1):13-27.
Hauck ML, Zalutsky MR. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: timing of injection relative to hyperthermia. International Journal of Hyperthermia 2005;21(1):1-11.
Williams LE, Johnson JL, Hauck ML, Ruslander DM, Price GS, Thrall DE. Chemotherapy followed by half-body radiation therapy for canine lymphoma. Journal of Veterinary Internal Medicine 2004;18(5):703-709.
Proulx DR, Ruslander DM, Dodge RK, Hauck ML, Williams LE, Horn B, Price GS, Thrall DE. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Veterinary Radiology and Ultrasound 2003;44(3):352-359.
Bailey D, Erb H, Williams L, Ruslander D, Hauck M. Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog. Journal of Veterinary Internal Medicine 2003;17(2):199-205.
Kobayashi TK, Hauck ML, Dodge R, Page RL, Price GS, Williams LE, Hardie EM, Mathews KG, Thrall DE. Preoperative radiation therapy for vaccine site sarcoma in 92 cats. Veterinary Radiology and Ultrasound 2002;43:473-479.
DeFrancesco TC, Atkins CE, Keene BW, Coats JR, Hauck ML. Prospective clinical evaluation of serum cardiac troponin T in dogs admitted to a veterinary teaching hospital. Journal of Veterinary Internal Medicine 2002;16:553-557.
Dickerson
ME, Page RL, LaDue TA, Hauck ML, Thrall
DE, Stebbins ME, Price GS. Retrospective
Analysis of Axial Skeleton Osteosarcoma in 22 Large-Breed
Dogs. Journal of Veterinary Internal Medicine 2001;15:120-124.
Case
BC, Hauck ML, Yeager RL, Simkins AH, De Serres M,
Schmith VD, Dillberger JE, Page RL. The pharmacokinetics
and pharmacodynamics of GW395058, a peptide agonist
of the thrombopoietin receptor, in the dog, a large-animal
model of chemotherapy-induced thrombocytopenia. Stem
Cells 2000;18(5):360-365.
Ramirez
O, Dodge RK, Page RL, Price GS, Hauck ML, LaDue TA,
Nutter F, Thrall DE. Palliative radiotherapy of appendicular
osteosarcoma in 95 dogs. Veterinary Radiology and Ultrasound
1999;40(4):517-522.
LaDue
TA. Dodge R, Page RL, Price GS, Hauck ML, Thrall DE.
Factors influencing survival after radiotherapy of nasal
tumors in 130 dogs. Veterinary Radiology and Ultrasound
1999;40:312-317.
Hauck
ML, Zalutsky MR. The effects of local hyperthermia on
the catabolism of a radioiodinated chimeric monoclonal
antibody. Clinical Cancer Research 1998; 4: 2071-2077.
Hauck
ML, Larsen RH, Welsh PC, Zalutsky MR. Cytotoxicity of
a-particle emitting 211At-labeled monoclonal antibody
in tumor spheroids: effect of moderate hyperthermia.
British Journal of Cancer 1998;77:753-759.
Hauck
ML, Coffin DO, Dodge RK, Dewhirst MW, Mitchell JB, Zalutsky
MR. Hyperthermia does not effect tumor interstitial
fluid pressure in a human glioma xenograft model. International
Journal of Hyperthermia 1997;13:307-316.
Hauck
ML, Dewhirst MW, Bigner DD, Zalutsky MR. Local hyperthermia
improves uptake of a chimeric monoclonal antibody in
a subcutaneous xenograft model. Clinical Cancer Research
1997;3:63-70.
Hauck
ML, Price GS, Ogilvie GK, Johnson J, Gillette EL, Thrall
DE, Dewhirst MW, Page RL. Phase I evaluation of mitoxantrone
alone and combined with whole body hyperthermia in dogs
with lymphoma. International Journal of Hyperthermia
1996;12:309-320.
Hauck
ML, Dewhirst MW, Zalutsky MR. The effects of clinically
relevant hyperthermic temperatures on the kinetic binding
parameters of the anti-tenascin monoclonal antibody
81C6. Journal of Nuclear Medicine and Biology 1996;23:551-557.
Hauck
ML. Editorial comment. International Journal of Hyperthermia
1996;12:827-829.
Page
RL, McEntee MC, Williams PL, George SL, Price GS, Novotney
CA, Hauck ML, Riviere JE, Dewhirst MW, Thrall DE. Effect
of whole body hyperthermia on carboplatin disposition
and toxicity in dogs. International Journal of Hyperthermia
1994;10:807-816.
Thrall
DE, McEntee MC, Novotney C, Hauck ML, Page RL. A boost
technique for irradiation of malignant canine nasal
tumors. Veterinary Radiology and Ultrasound 1993;34(4):295-300.
Page
RL, Thrall DE, George SL, Price GS, Heidner GL, McEntee
MC, Novotney CA, Hauck ML, Dewhirst MW. Quantitative
estimation of the thermal dose-modifying factor for
Dis-diamminedichloroplatinum (CDDP) in tumor-bearing
dogs. International Journal of Hyperthermia 1992; 8(6):761-769.
Book
Chapters
Hauck ML. Injection site sarcomas. In Kitchell BE (ed) Veterinary Clinics of North America-Update in Medical Oncology. W. B. Saunders, Philadephia, PA, May 2003, 553-571.
Hauck
ML, Dewhirst MW, Zalutsky MR. Enhancement of radiolabeled
monoclonal antibody uptake in tumors with local hyperthermia.
In Torchilin VP (ed) Handbook of Targeted Delivery
of Imaging Agents. CRC Press, Boca Raton, FL, 1995,
333-359.
Return to Top
|